Effective evaluation of trazodone in treatment of sleep disorders and mood disorder for methamphetamine addicts after detoxification

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005681

Enrollment

Unknown

Registered

2014-12-15

Start date

2015-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

methamphetamine dependence

Interventions

A:trazodone

B:Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 55 years old, male or female; 2. Primary school or above degree; 3. Diagnosis is based on the DSM-IV - methamphetamine dependence diagnostic criteria; 4. Negative urinary test for methamphetamine after 10-day acute detoxification; 5. To be able to and willing to provide signed informed consent; 6. No mental retardation and able to read and understand the questionnaire.

Exclusion criteria

Exclusion criteria: 1. With other genetic diseases, serious physical illness, nervous diseases and mental disorders; 2. Poly-drug abuse (more than 1 time per month); 3. Poor compliance, can not be in line with the interview; 4. Currently participating in other clinical trials.

Design outcomes

Primary

Measure	Time frame
Pittsburgh Sleep Quality Index;Hamilton Anxiety Scale;Hamilton Depression Scale;liver function;renal function;	—

Contacts

Public ContactWenhua ZHOU

whzhou@vip.163.com+86 574 87145142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026